BTL Industries
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, BTL Industries sits in the top decile of US sponsors by registered trial count (#434 of 15,742 sponsors by registered trial count).
BTL Industries: 40 sponsored US clinical trials, 3 recruiting.
BTL Industries sponsors 40 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 34 completed. The most-studied condition in this pipeline is Urinary Incontinence, with 3 trials.
Top-decile sponsor footprint
BTL Industries ranks in the top decile of sponsors by registered trial count (#434 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
34 of 34 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
40 total, page 1 of 1
BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Urinary Incontinence in Postpartum and Early Post-Childbirth Women
NCT07413692
BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and Postmenopausal Women
NCT07413705
EXOMIND (BTL-699-2) for the Improvement of Sleep Quality and Reduction of Stress
NCT07027657
EMVITAL + EMFACE Combination Therapy for Temporomandibular Joint (TMJ) Pain Relief
NCT07661121
HIFEM and Radiofrequency for Muscular System Function Improvement
NCT06703749
rTMS Device for Improvement of Obsessive and Compulsive Behaviors
NCT07679750
EXOMIND (BTL-699-2) for the Improvement in Willpower & Food Cravings
NCT07056036
Device for Alleviating Temporomandibular Joint (TMJ) Pain
NCT07624539
Safety and Efficacy of the BTL-043 Device in Alleviating Back Pain
NCT07661082
EXOMIND (BTL-699-2) for Improvement of Mental Well-being
NCT06899646
Device for Improving Skin Quality and Texture on the Face and Neck
NCT06645366
HIFEM for Musculoskeletal System Improvement
NCT06677086
Evaluation of the BTL-785F Device for Submental Fat Reduction and Neck Rejuvenation
NCT06274177
Histological Evaluation of BTL-785F Device's Effect on Submental Subcutaneous Adipose Tissue
NCT06282172
Combination of BTL-785F and HPM-6000UF Devices for Women's Intimate Wellness
NCT06846216
BTL-785F Device for Non-invasive Reduction of Wrinkles and Overall Facial Improvement
NCT05524779
BTL-785F Device for Non-invasive Facial Rejuvenation in Patients Injected With Botulinum Toxin
NCT05524766
BTL-785F Device for Non-invasive Treatment of Wrinkles and Improvement of the Face Appearance
NCT05524805
BTL-785F Device for Improving the Structure of Facial Muscles
NCT05524740
Clinical and Histological Evaluation of BTL-785F Device for Non-invasive Treatment of Face
NCT05524662
Non-invasive Lipolysis and Improvement of Muscle Tone in Lateral Abdomen
NCT05540080
Combination Treatment With BTL-899 and HPM-6000UF Devices II
NCT05713864
Evaluation of Safety and Efficacy of the BTL-785F Device for Non-invasive Facial Remodeling
NCT05525026
BTL-785F Device for Non-invasive Reduction of Wrinkles
NCT05519124
Histological Evaluation of BTL-899 Device´s Effect on Fat Tissue
NCT05139745
High-Intensity Focused Electromagnetic Procedure and Radiofrequency for Toning of Buttocks
NCT04871503
Clinical and Histological Evaluation of BTL-785F Non-invasive Treatment for Facial Rejuvenation
NCT05987917
Fractional Radiofrequency for Treatment of Acne Scars and Wrinkles
NCT05827510
Radiofrequency and Ultrasound for Improvement of Skin Laxity and Wrinkles: Efficacy and Safety Evaluation
NCT05929625
Non-invasive Lipolysis and Improvement of Muscle Tone in Inner Thighs
NCT04596228
Non-invasive Lipolysis and Improvement of Muscle Tone in Upper Arms
NCT04596241
Fat Reduction and Muscle Toning of Thighs
NCT04599257
rPMS and Radiofrequency for Abdominal Toning and Reduction of Subcutaneous Fat
NCT04587986
Radiofrequency and Targeted Pressure Energy for Cellulite Reduction
NCT05624216
Abdomen - Fat Reduction and Muscle Toning
NCT04587804
rPMS Compared With Pelvic Floor Exercises for Treatment of Urinary Incontinence
NCT03969368
HIFEM for Arms, Lower Limbs, and Oblique Muscles
NCT04426526
Efficacy of rPMS for Improvement of Urinary Incontinence and Female Sexual Function
NCT03942484
MRI Evaluation of Change in Gluteal Muscles Following the Treatment With HIFEM Device
NCT03815747
High-Intensity Focused Electromagnetic (HIFEM) Field Device in Women After Childbirth
NCT03758690
Therapeutic Areas
What is open in the BTL Industries pipeline
3 recruiting of 40 indexed (8% open); 34 completed (85%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Urinary Incontinence (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
BTL Industries: open-pipeline peers nationwide
Peers matched on 40 registered trials and 8% open enrollment, not the therapeutic-area sidebar.
BTL Industries sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 40 trials (± recruiting share)
- Baptist Health South Florida · 40 trials · 43% recruiting
- Celgene Corporation · 40 trials · 0% recruiting
- Harvard School of Public Health (HSPH) · 40 trials · 3% recruiting
- Intuitive Surgical · 40 trials · 8% recruiting
Sponsors near 8% open enrollment (± trial volume)
- Louisiana State University Health Sciences Center Shreveport · 8% recruiting · 40 trials
- University of Kansas · 8% recruiting · 66 trials
- Akron Children's Hospital · 7% recruiting · 27 trials
- AVEO Pharmaceuticals · 7% recruiting · 27 trials
Related
What to do with this BTL Industries page
40 registered trials is a research-attention snapshot, not an endorsement of BTL Industries or any single study.
- 3 of BTL Industries's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Urinary Incontinence is the condition BTL Industries studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Urinary Incontinence trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
BTL Industries pipeline card: 40 registered trials from official public datasets.Report a data error.